H
GILD icon

HoyleCohen’s Gilead Sciences GILD Stock Holding History

HoyleCohen’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$1.39M Sell
20,300
-605
-3% -$40.4K 0.11% 124
2024
Q1 		$1.53M Sell
20,905
-1,925
-8% -$148K 0.12% 130
2023
Q4 		$1.85M Buy
22,830
+327
+1% +$25.4K 0.15% 118
2023
Q3 		$1.69M Sell
22,503
-70
-0.3% -$5.38K 0.16% 114
2023
Q2 		$1.74M Buy
22,573
+25
+0.1% +$1.99K 0.15% 117
2023
Q1 		$1.87M Sell
22,548
-422
-2% -$35K 0.17% 116
2022
Q4 		$1.97M Sell
22,970
-1,188
-5% -$94.1K 0.2% 107
2022
Q3 		$1.49M Sell
24,158
-28,843
-54% -$1.82M 0.16% 111
2022
Q2 		$3.28M Sell
53,001
-2,325
-4% -$144K 0.34% 76
2022
Q1 		$3.29M Sell
55,326
-8,304
-13% -$531K 0.28% 85
2021
Q4 		$4.62M Sell
63,630
-3,948
-6% -$272K 0.38% 70
2021
Q3 		$4.72M Sell
67,578
-4,547
-6% -$319K 0.45% 65
2021
Q2 		$4.97K Sell
72,125
-1,373
-2% -$91.7K 0.39% 63
2021
Q1 		$4.75M Sell
73,498
-212
-0.3% -$13.7K 0.48% 63
2020
Q4 		$4.29M Sell
73,710
-1,455
-2% -$87.8K 0.5% 58
2020
Q3 		$4.75M Sell
75,165
-1,921
-2% -$133K 0.7% 37
2020
Q2 		$5.93M Sell
77,086
-1,633
-2% -$125K 0.99% 26
2020
Q1 		$5.88M Sell
78,719
-1,606
-2% -$111K 1.17% 25
2019
Q4 		$5.22M Sell
80,325
-3,245
-4% -$211K 0.83% 38
2019
Q3 		$5.3M Sell
83,570
-395
-0.5% -$25.8K 0.9% 36
2019
Q2 		$5.67M Buy
83,965
+350
+0.4% +$23K 0.98% 32
2019
Q1 		$5.44M Sell
83,615
-1,685
-2% -$112K 0.96% 32
2018
Q4 		$5.34M Sell
85,300
-2,142
-2% -$150K 1.09% 30
2018
Q3 		$6.75M Buy
87,442
+877
+1% +$66.2K 1.27% 27
2018
Q2 		$6.13M Sell
86,565
-1,142
-1% -$80.6K 1.24% 27
2018
Q1 		$6.61M Buy
87,707
+1,133
+1% +$90.1K 1.34% 29
2017
Q4 		$6.2M Buy
+86,574
New +$6.57M 1.23% 30

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HoyleCohen's GILD Position: Q2 2024 in Review

HoyleCohen reduced its Gilead Sciences (GILD) stake by 2.9% in Q2 2024, selling an estimated $40.4K and leaving 20,300 shares worth $1.39M. The position accounts for 0.11% of the portfolio, ranked #124.

HoyleCohen first reported a position in GILD in Q4 2017 and has held it in 27 quarters since. The position peaked at $6.75M in Q3 2018. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • HoyleCohen held 20,300 shares of Gilead Sciences worth $1.39M as of Q2 2024.
  • HoyleCohen sold 605 Gilead Sciences shares in Q2 2024, an estimated $40.4K.
  • Gilead Sciences made up 0.11% of HoyleCohen's portfolio in Q2 2024, its #124 holding.
  • HoyleCohen first reported a position in Gilead Sciences in Q4 2017 and has held it in 27 quarters since.
  • HoyleCohen's Gilead Sciences position peaked at $6.75M in Q3 2018.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.